Cultured enzyme-linked immunospot assay (ELISPOT) enhances detection of low HIV-specific immune responses in exposed seronegative individuals in Kenya

Cultured enzyme-linked immunospot assay (ELISPOT) enhances detection of low HIV-specific immune responses in exposed seronegative individuals in Kenya

Bibliographic Details
Main Authors:	Anzala Omu, Mutua Gaudensia, Gichuki Charity, Muturi Margaret
Format:	Article
Language:	English
Published:	BMC 2006-12-01
Series:	Retrovirology

Similar Items

Development and evaluation of a Mycobacterium bovis interferon-γ enzyme-linked immunospot (ELISpot) assay for detection of bovine tuberculosis
by: Xin Li, et al.
Published: (2022-07-01)

Characterization of Varicella-Zoster (VZV) Specific T Cell Response in Healthy Subjects and Transplanted Patients by Using Enzyme Linked Immunospot (ELISpot) Assays
by: Irene Cassaniti, et al.
Published: (2021-08-01)

Diagnosis of Tuberculosis by an Enzyme-Linked Immunospot Assay for Interferon-γ
by: Jann-Yuan Wang, et al.
Published: (2007-04-01)

Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium
by: Gwenn Waerlop, et al.
Published: (2022-09-01)

Chronic-Relapsing cutaneous leukocytoclastic vasculitis in a young patient with reduced EBV-specific T cell response using enzyme-linked immunospot (ELISPOT) assay successfully treated with Valaciclovir
by: Caterina Foti, et al.
Published: (2021-01-01)

Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines.
by: Mwau, M, et al.
Published: (2002)

Use of Pleural Fluid Interferon-gamma Enzyme-linked Immunospot Assay in the Diagnosis of Pleural Tuberculosis
by: Tika Adilistya, et al.
Published: (2016-09-01)

Recruitment and Follow Up of High Risk HIV Negative Volunteers in Preparation For Vaccine Trials, Kenyan Case
by: Odada Jane, et al.
Published: (2005-12-01)

A modified anthrax toxin-based enzyme-linked immunospot assay reveals robust T cell responses in symptomatic and asymptomatic Ebola virus exposed individuals.
by: Bobby Brooke Herrera, et al.
Published: (2018-05-01)

Development of a rapid neutralization testing system for Rhinovirus C15 based on the enzyme-linked immunospot assay
by: Zhenhong Zhou, et al.
Published: (2022-09-01)

Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.
by: Borna A Nyaoke, et al.
Published: (2017-01-01)

Evaluation of an enzyme-linked immunospot assay for the immunodiagnosis of atypical spinal tuberculosis (atypical clinical presentation/atypical radiographic presentation) in China
by: Kai Yuan, et al.
Published: (2013-09-01)

Bronchoalveolar lavage enzyme-linked immunospot for diagnosis of smear-negative tuberculosis in HIV-infected patients.
by: Adithya Cattamanchi, et al.
Published: (2012-01-01)

Usefulness of BK virus-specific interferon-γ enzyme-linked immunospot assay for predicting the outcome of BK virus infection in kidney transplant recipients
by: Hyunjoo Bae, et al.
Published: (2021-01-01)

Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents.
by: Boaz, M, et al.
Published: (2009)

Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria.
by: Keating, S, et al.
Published: (2005)

Comparison between enzyme‐linked immunospot assay and intracellular cytokine flow cytometry assays for the evaluation of T cell response to SARS‐CoV‐2 after symptomatic COVID‐19
by: Juliette Villemonteix, et al.
Published: (2022-10-01)

Blunted IL17/IL22 and pro-inflammatory cytokine responses in the genital tract and blood of HIV-exposed, seronegative female sex workers in Kenya.
by: Duncan Chege, et al.
Published: (2012-01-01)

Complete mapping of a novel HLA A*6801-restricted HIV-1 Tat epitope directly with a rapid modified enzyme-linked immunospot assay.
by: Oxenius, A, et al.
Published: (2002)

Feasibility of conducting HIV prevention trials among key populations in Nairobi, Kenya
by: Elizabeth Mueni Mutisya, et al.
Published: (2022-12-01)

Acceptability and feasibility of repeated mucosal specimen collection in clinical trial participants in Kenya.
by: Gloria Omosa-Manyonyi, et al.
Published: (2014-01-01)

Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay.
by: Altfeld, M, et al.
Published: (2000)

ELISPOT Cell Analysis Assay: Searching for Extracellular Footprints
by: Alexander E. Kalyuzhny
Published: (2011-09-01)

Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays
by: Sebastian Köppert, et al.
Published: (2021-07-01)

Utility of interferon-γ ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa
by: Ntobongwana Marjorie, et al.
Published: (2007-08-01)

Cultured ELISpot assay to investigate dengue virus specific T-cell responses
by: Jeewandara, C, et al.
Published: (2018)

Dissecting the T Cell Response: Proliferation Assays vs. Cytokine Signatures by ELISPOT
by: Magdalena Tary-Lehmann, et al.
Published: (2012-05-01)

Stepping up ELISpot: Multi-Level Analysis in FluoroSpot Assays
by: Sylvia Janetzki, et al.
Published: (2014-11-01)

Role of ELISPOT Assays in Risk Assessment Pre- and Post-Kidney Transplantation
by: Anat R. Tambur, et al.
Published: (2012-05-01)

Development of an EliSPOT assay for detection of CMV-specific immune response
by: Maria Elena Terlizzi, et al.
Published: (2010-06-01)

Equivalence of ELISpot assays demonstrated between major HIV network laboratories.
by: Dilbinder K Gill, et al.
Published: (2010-12-01)

ELISPOT assay of the SARS-CoV-2 specific T cells immune response
by: V. V. Gerasimova, et al.
Published: (2022-12-01)

Effect of cryopreservation of peripheral blood mononuclear cells (PBMCs) on the variability of an antigen-specific memory B cell ELISpot: Variability of the memory B cell ELISpot assay.
by: Trück, J, et al.
Published: (2014)

A novel rabbit immunospot array assay on a chip allows for the rapid generation of rabbit monoclonal antibodies with high affinity.
by: Tatsuhiko Ozawa, et al.
Published: (2012-01-01)

Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults-Experience from Kenya.
by: Delvin Kwamboka Nyasani, et al.
Published: (2018-01-01)

Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants.
by: Slyker, J, et al.
Published: (2005)

An Enhanced ELISPOT Assay for Sensitive Detection of Antigen-Specific T Cell Responses to Borrelia burgdorferi
by: Gottfried H. Kellermann, et al.
Published: (2013-09-01)

ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials
by: Thomas J. Sayers, et al.
Published: (2012-05-01)

Comparision of Tuberculin Skin Test and RD1-ELISPOT Assay in Health Care Workers
by: Ahmet SOYSAL, et al.
Published: (2005-09-01)

Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay
by: Baseler Michael, et al.
Published: (2004-09-01)